Technical Analysis for REPH - Recro Pharma, Inc.

Grade Last Price % Change Price Change
grade B 8.99 0.45% 0.04
REPH closed up 0.45 percent on Friday, May 17, 2019, on 47 percent of normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Up Up Flat
See historical REPH trend table...

Date Alert Name Type % Chg
MACD Bearish Signal Line Cross Bearish 0.00%
20 DMA Support Bullish 0.00%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 0.00%
Inside Day Range Contraction 0.45%
Upper Bollinger Band Touch Strength 0.45%
180 Bullish Setup Bullish Swing Setup -4.36%
Outside Day Range Expansion -4.36%
Above Upper BB Strength -4.36%
Upper Bollinger Band Touch Strength -4.36%
Earnings Movers Other 1.01%

Older signals for REPH ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Recro Pharma, Inc., a clinical stage specialty pharmaceutical company, is engaged in the development of various non-opioid therapeutics for the treatment of pain and related conditions in the United States. The company is developing intranasal formulation of Dexmedetomidine (Dex) for the treatment of post-operative pain and cancer breakthrough pain; sublingual formulation of Dex for the treatment of chronic pain; and Fadolmidine (Fado), a product candidate to treat post-operative pain and neuropathic pain. It has a license agreement with Orion Corporation for the development and commercialization of Dex and Fado. The company was formerly known as Recro Pharma I, Inc. and changed its name to Recro Pharma, Inc. in August 2008. Recro Pharma, Inc. was founded in 2007 and is based in Malvern, Pennsylvania.
Medicine Pain Chronic Pain Perception Stage Specialty Pharmaceutical Imidazoles Neuropathic Pain Sensory Systems
Is REPH a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 3 bullish, 0 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 13.05
52 Week Low 4.78
Average Volume 545,671
200-Day Moving Average 7.5781
50-Day Moving Average 8.3774
20-Day Moving Average 8.8085
10-Day Moving Average 8.979
Average True Range 0.4387
ADX 23.31
+DI 28.0027
-DI 12.1605
Chandelier Exit (Long, 3 ATRs ) 8.2639
Chandelier Exit (Short, 3 ATRs ) 9.1661
Upper Bollinger Band 9.3927
Lower Bollinger Band 8.2243
Percent B (%b) 0.66
BandWidth 13.26446
MACD Line 0.2147
MACD Signal Line 0.2187
MACD Histogram -0.004
Fundamentals Value
Market Cap 171.34 Million
Num Shares 19.1 Million
EPS -2.12
Price-to-Earnings (P/E) Ratio -4.24
Price-to-Sales 2.35
Price-to-Book 2.89
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 9.62
Resistance 3 (R3) 9.63 9.42 9.52
Resistance 2 (R2) 9.42 9.26 9.42 9.48
Resistance 1 (R1) 9.21 9.16 9.32 9.20 9.44
Pivot Point 9.00 9.00 9.06 9.00 9.00
Support 1 (S1) 8.79 8.84 8.90 8.78 8.54
Support 2 (S2) 8.58 8.74 8.58 8.50
Support 3 (S3) 8.37 8.58 8.47
Support 4 (S4) 8.36